Alpha Tau Medical (DRTS) Enterprise Value (2020 - 2026)
Alpha Tau Medical (DRTS) posted Enterprise Value of -$76.4 million for Q1 2026, down 4.5% sequentially from -$73.1 million in Q4 2025, and down 48.0% YoY from -$146.9 million in Q1 2025.
Alpha Tau Medical (DRTS) Enterprise Value (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Enterprise Value for 7 years, with the latest figure at -$76.4 million in Q1 2026.
- Quarterly Enterprise Value fell 48.0% year-over-year to -$76.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$76.4 million (down 48.0% YoY) and the FY2025 annual result came in at -$73.1 million, down 22.69% from the prior year.
- Enterprise Value fell to -$76.4 million in Q1 2026 per DRTS's latest filing, from -$73.1 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$51.6 million in Q1 2025 and troughed at -$8.2 billion in Q1 2022.
- A 5-year average of -$559.1 million and a median of -$79.7 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value tumbled 68881.88% in 2022, then surged 98.78% in 2023.
- Over 5 years, Enterprise Value stood at -$104.5 million in 2022, then advanced by 21.76% to -$81.8 million in 2023, then increased by 27.13% to -$59.6 million in 2024, then decreased by 22.69% to -$73.1 million in 2025, then dropped by 4.5% to -$76.4 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$76.4 million, -$73.1 million, and -$72.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | -182.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -182.42 Mn |
| Mar 31, 2026 | -76.42 Mn |
| Dec 31, 2025 | -73.13 Mn |
| Sep 30, 2025 | -72.21 Mn |
| Jun 30, 2025 | -79.70 Mn |
| Mar 31, 2025 | -51.64 Mn |
| Dec 31, 2024 | -59.60 Mn |
| Sep 30, 2024 | -65.22 Mn |
| Jun 30, 2024 | -71.03 Mn |
| Mar 31, 2024 | -77.55 Mn |
| Dec 31, 2023 | -81.79 Mn |
| Sep 30, 2023 | -87.22 Mn |
| Jun 30, 2023 | -94.36 Mn |
| Mar 31, 2023 | -99.65 Mn |
| Dec 31, 2022 | -104.53 Mn |
| Sep 30, 2022 | -107.67 Mn |
| Jun 30, 2022 | -112.83 Mn |
| Mar 31, 2022 | -8.19 Bn |
| Dec 31, 2021 | -31.32 Mn |
| Mar 31, 2021 | -11.87 Mn |